Tumor Protein D52-Like 2 (TPD52L2) (Middle Region) Peptid
TPD52L2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle TPD52L2 Produkte
- TPD52L2 (Tumor Protein D52-Like 2 (TPD52L2))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- GEWNEKVTQS DLYKKTQETL SQAGQKTSAA LSTVGSAISR KLGDMRNSAT
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- TPD52L2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TPD52L2 (Tumor Protein D52-Like 2 (TPD52L2))
- Hintergrund
-
This gene encodes a member of the tumor protein D52-like family. These proteins are characterized by an N-terminal coiled-coil motif that is used to form homo- and heteromeric complexes with other tumor protein D52-like proteins. Expression of this gene may be a marker for breast cancer and acute lymphoblastic leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 12.
Alias Symbols: D54, TPD54
Protein Size: 229 - Gen-ID
- 7165
- NCBI Accession
- NM_001243892, NP_001230821
-
Sie sind hier:
